CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
CollPlant Biotechnologies (NASDAQ: CLGN), a company focused on regenerative and aesthetics medicine using non-animal-derived recombinant human collagen technology, has announced its participation in the 27th Annual H.C. Wainwright Global Investment Conference.
The conference will take place on September 8-9, 2025, at the Lotte New York Palace Hotel. Senior management will be available for one-on-one meetings with investors, which can be arranged through H.C. Wainwright representatives or via [email protected].
CollPlant Biotechnologies (NASDAQ: CLGN), azienda specializzata in medicina rigenerativa ed estetica che utilizza tecnologia di collagene umano ricombinante di origine non animale, ha annunciato la sua partecipazione alla 27陋 Annuale H.C. Wainwright Global Investment Conference.
La conferenza si terr脿 l鈥�8 e il 9 settembre 2025 presso il Lotte New York Palace Hotel. Il top management sar脿 disponibile per incontri one-to-one con gli investitori, prenotabili tramite i rappresentanti di H.C. Wainwright o scrivendo a [email protected].
CollPlant Biotechnologies (NASDAQ: CLGN), compa帽铆a centrada en medicina regenerativa y est茅tica que utiliza tecnolog铆a de col谩geno humano recombinante de origen no animal, ha anunciado su participaci贸n en la 27.陋 Conferencia Anual Global de Inversi贸n H.C. Wainwright.
La conferencia se celebrar谩 los 8 y 9 de septiembre de 2025 en el Lotte New York Palace Hotel. La alta direcci贸n estar谩 disponible para reuniones individuales con inversores, que pueden organizarse a trav茅s de los representantes de H.C. Wainwright o en [email protected].
CollPlant Biotechnologies (NASDAQ: CLGN)電� 霃欕 鞙犽灅臧� 鞎勲媽 鞛“頃� 鞚戈皠 旖滊澕瓴� 旮办垹鞚� 頇滌毄頃� 鞛儩 氚� 氙胳毄 鞚橅暀鞐� 欤茧牓頃橂姅 旮办梾鞙茧, 鞝�27須� 鞐半 H.C. Wainwright 旮�搿滊矊 韴瀽 旎嵓霟办姢鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟.
旎嵓霟办姢电� 2025雲� 9鞗� 8鞚紐9鞚�鞐� 搿嵃 雺挫殨 韺半Μ鞀� 順疙厰鞐愳劀 鞐措雼堧嫟. 瓴届榿歆勳潃 韴瀽鞛愳檧鞚� 鞚茧寑鞚� 氙疙寘鞐� 鞚戫暊 鞓堨爼鞚措┌, H.C. Wainwright 雼措嫻鞛愲ゼ 韱淀暣 霕愲姅 [email protected]鞙茧 鞓堨暯頃� 靾� 鞛堨姷雼堧嫟.
CollPlant Biotechnologies (NASDAQ: CLGN), soci茅t茅 sp茅cialis茅e en m茅decine r茅g茅n茅rative et esth茅tique utilisant une technologie de collag猫ne humain recombinant d鈥檕rigine non animale, a annonc茅 sa participation 脿 la 27e Conf茅rence Annuelle Mondiale H.C. Wainwright.
La conf茅rence se d茅roulera les 8 et 9 septembre 2025 au Lotte New York Palace Hotel. La direction sera disponible pour des r茅unions individuelles avec des investisseurs, pouvant 锚tre organis茅es via les repr茅sentants de H.C. Wainwright ou 脿 l鈥檃dresse [email protected].
CollPlant Biotechnologies (NASDAQ: CLGN), ein Unternehmen, das sich auf regenerative und 盲sthetische Medizin mit nicht-tierischem rekombinantem humanen Kollagen konzentriert, hat seine Teilnahme an der 27. j盲hrlichen H.C. Wainwright Global Investment Conference 补苍驳别办眉苍诲颈驳迟.
Die Konferenz findet am 8. und 9. September 2025 im Lotte New York Palace Hotel statt. Die Gesch盲ftsf眉hrung steht f眉r Einzelgespr盲che mit Investoren zur Verf眉gung, die 眉ber die Vertreter von H.C. Wainwright oder per E-Mail an [email protected] arrangiert werden k枚nnen.
- None.
- None.
REHOVOT,
Investors attending the event may request a one-on-one meeting with CollPlant through their H.C. Wainwright representative or e-mail [email protected].
About CollPlant
CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.
In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.
For more information about CollPlant, visit聽.
Contacts
CollPlant:
Eran Rotem
Deputy CEO & CFO
+972-73-2325600
[email protected]
Investors:
LifeSci Advisors
Dan Ferry
[email protected]
Logo: https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg
View original content:
SOURCE CollPlant
FAQ
When is CollPlant (NASDAQ:CLGN) presenting at the H.C. Wainwright Conference 2025?
How can investors meet with CollPlant management at the H.C. Wainwright Conference?
What is CollPlant Biotechnologies' main technology focus?
Where will the H.C. Wainwright Global Investment Conference 2025 be held?
